Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Saving money before the holidays can help you enjoy the festivities without financial stress. Here are effective ways to prepare your budget.
17,936 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Mark Cuban is reviving the debate over wage inequality by urging companies to grant stock to every worker. His pitch ...
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
SoundHound AI aims to own the voice layer that connects users to services. This article builds a practical bull case ...
Meta CEO Mark Zuckerberg faced lawmakers over under-13 Instagram use and the effectiveness of age checks. The session...
A bold claim from a tech titan can set off a market ripple. This article breaks down what elon musk just claimed coul...
Goodyear reports a strong Q4 with $105 million in profit, while an investor increases exposure to $15 million. This p...
A large insider purchase by Conagra's CEO has investors buzzing. Learn what insider buying signals really mean, how t...
MBA researchers project 2025 real GDP around 2.5% with consumer spending staying resilient, while FHA delinquencies r...
On Feb 18, KVUE defied expectations with a stronger quarter, lifting the stock even as the market edged higher. Here’...
Kadant is navigating 2025 with a mix of packaging strength and manufacturing headwinds. This guide breaks down what t...
At a key investor conference, Micron revealed strategic moves and market signals that could alter its trajectory. Her...